Q32 Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Q32 Bio Inc. (QTTB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-47.73-112.96-42.81-37.56-128.69-103.92-55.58
Depreciation & Amortization0.49-2.370.370.057.776.321.29
Stock Based Compensation4.391.431.240.750.000.000.00
Change in Working Capital-9.64-14.6326.943.6813.770.4610.57
Change in Accounts Payable-1.042.03-1.241.100.000.000.00
Change in Other Working Capital-8.5950.132.342.580.000.000.00
Other Operating Activities-17.4933.833.1816.0311.945.760.00
Net Cash from Operating Activities-67.72-96.23-10.96-32.98-94.33-91.36-42.56
Investing Activities
Capital Expenditures-0.080.23-2.49-0.163.7321.83-24.94
Acquisitions0.000.00130.000.000.000.000.00
Purchases of Investments20.000.000.000.000.000.000.00
Sales/Maturities of Investments20.00101.00-92.00-48.39208.63-29.97-96.85
Net Cash from Investing Activities19.93101.33-2.47-0.16204.90-51.80-121.79
Financing Activities
Debt Repayment7.00-5.200.000.000.000.000.00
Common Stock Issued43.690.170.070.1252.92135.35150.91
Other Financing Activities44.440.000.000.000.000.000.00
Net Cash from Financing Activities95.140.1830.0720.1153.09135.70150.99
Summary
Net Change in Cash47.355.2816.65-13.03163.66-7.45-13.36
Cash at Beginning of Period31.2633.9932.89218.7155.0539.9953.35
Cash at End of Period78.6139.2733.99110.34218.7132.5439.99
Free Cash Flow-67.79-95.90-13.44-33.14-98.07-113.19-67.50
Supplemental Disclosures
Income Taxes Paid0.000.000.720.000.000.000.00